Research Performed at Progressive Gastroenterology Leads to FDA Approval of Linzess (Linaclotide) for the Treatment of Irritable Bowel Syndrome and Chronic Constipation
Linzess (Linaclotide) has been shown to be safe and effective for Constipation Predominant Irritable Bowel Syndrome (IBS-C) and Chronic Constipation (CC).
Continue reading